Technicals for Piramal Pharma Limited

Price Summary

On 2026-07-01, Piramal Pharma Limited's stock began at 168.68, peaked at 173.1, bottomed at 167.15, and closed -0.08% lower at 168.54, with a volume of 4753135 shares.
Over the course of 52 weeks, the stock peaked at 216.88 and hit a low of 133.27.

Technicals

Support and Resistance: At 168.54, the price is supported by 167.73 and resisted by 178.86. This indicates that the price for Piramal Pharma Limited might fluctuate between these levels, with 167.73 acting as a support and 178.86 limiting further upward movement.


Aroon: The AROON is currently in a neutral position for Piramal Pharma Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.


Bol. Bands: The BOLL BANDS is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.


Parabolic SAR: The PSAR maintains a bullish outlook, reinforcing a support level that could help uphold the market's upward trend. This suggests that the market is likely to continue climbing, with the support providing a solid base for further gains.


Stochastic: The STOCHASTIC is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.


Tripple Moving Agerage: The Tripple MOVING AVG is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.


A company's technical data, including stock price and trading volume, can provide valuable insights when considered alongside its fundamentals. These include financial performance, market share, and growth strategy, as well as broader industry dynamics. Examining these factors helps investors or analysts make more informed decisions, as the company's fundamentals offer context for understanding how and why certain technical patterns may emerge in the market.